Parisa Zamiri
Plus aucun poste en cours
Fortune : 119 841 $ au 31/03/2024
Profil
Parisa Zamiri worked as the Director-Pre-Clinical Sciences at Arsenal Medical, Inc. from 2007 to 2011.
She then served as the VP & Global Head-Clinical Development at Novartis AG from 2012 to 2020.
Dr. Zamiri was the Chief Medical Officer at Graybug Vision, Inc. from 2020 to 2023.
She also held the position of Chief Medical Officer at CalciMedica, Inc. Dr. Zamiri holds a doctorate degree from University College London and a graduate degree from King's College London.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
CALCIMEDICA, INC.
0,27% | 23/03/2023 | 28 808 ( 0,27% ) | 119 841 $ | 31/03/2024 |
Anciens postes connus de Parisa Zamiri
Sociétés | Poste | Fin |
---|---|---|
CALCIMEDICA, INC. | Chief Tech/Sci/R&D Officer | 28/02/2023 |
CALCIMEDICA, INC. | Chief Tech/Sci/R&D Officer | 28/02/2023 |
NOVARTIS AG | Corporate Officer/Principal | 01/06/2020 |
Arsenal Medical, Inc.
Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Corporate Officer/Principal | 01/11/2011 |
Formation de Parisa Zamiri
University College London | Doctorate Degree |
King's College London | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
NOVARTIS AG | Health Technology |
CALCIMEDICA, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Arsenal Medical, Inc.
Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Commercial Services |
Graybug Vision, Inc.
Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |